Neuro-imaging

P157 - Effect Of Ocrelizumab On QSM Chronic Active Lesions

Presenter
  • N. Safi
Author
  • N. Safi
  • S. Pandya
  • T. Nguyen
  • U. Kaunzner
  • N. Nealon
  • J. Perumal
  • T. Vartanian
  • Y. Wang
  • S. Gauthier
Session Title
Poster Session 1 / Opening Networking Event

Previous ePoster
P156 - Distribution-based Measures Of Quantitative Magnetic Susceptibility And R2* From 7-tesla Mri Are Associated With Disability In Multiple Sclerosis.

Next ePoster

No Preview Available
P158 - Fronto-striatal Microstructural Damage May Play A Role In The Development Of Resistance To Fatigue-lowering Medications In Multiple Sclerosis
No Preview Available
P159 - Gliomatosis Cerebri Mimicking Acute Disseminated Encephalomyelitis (ADEM)
P160 - Imaging Axonal Loss And Dysfunction Of Optic Nerve (ON) In Multiple Sclerosis (MS) Using Diffusion Basis Spectrum Imaging (dbsi) Multiple Sclerosis Using Diffusion Basis Spectrum Imaging (DBSI)
LB295 - Accelerated Disability Worsening Correlates With A Two-measure-pattern Of Elevated Plasma Nfl After Fingolimod Initiation In Patients With RRMS
LB297 - Leptomeningeal Enhancement Kinetics In Relapsing-Remitting MS
LB298 - Metabolic Abnormalities Associated With Phase Rims In Progressive MS
LB299 - Disability Improvement And Progression As Assessed By The Multiple Sclerosis Functional Composite In Progressive MS Patients From The Climb Study.
LB300 - Onset Of B-cell Depletion With Subcutaneous Administration Of Ofatumumab In Relapsing Multiple Sclerosis: Results From The APLIOS Bioequivalence Study
No Preview Available
LB301 - High Dose Vitamin D Worsens Experimental CNS Autoimmune Disease By Raising T Cell-excitatory Calcium
No Preview Available
LB303 - Potential for the Microbiome as a Therapeutic Target